Description de l'actif
JLL is proud to exclusively present for sale, Clinipath Pathology, Osborne Park, a state-of-the-art pathology laboratory underpinned by a global healthcare operator. The asset comprises of 4,997sqm* of premium pathology laboratory and office space. Located in Osborne Park, the asset benefits from close proximity to major transport infrastructure and key health facilities such as Osborne Park Hospital and Innaloo Medical Centre.
A 100% freehold interest in Clinipath Pathology, Osborne Park is for sale via Expressions of Interest (EOI) closing Tuesday 26 March 2024 at 2:00pm (AWST).
Caractéristiques de l'actif
Média
Points clés d'investissement
Wholly occupied by Sonic Healthcare’s Clinipath Pathology with a WALE of 9-years*, Clinipath Pathology, Osborne Park, provides substantial long term income security in a tightly held market.
- Highly specialised pathology laboratory with tenant investment of circa $37.5M supporting tenant retention.
- Long term lease to Clinipath Pathology Pty Ltd, a wholly owned subsidiary of global healthcare operator Sonic Healthcare (SHL) Australia’s 3rd largest healthcare company with $8.2Bn in revenue in 2023.
- Key infrastructure operating as Clinipath’s main laboratory servicing the entirety of Western Australia.
- Significant underlying landholding of 15,041sqm* with future expansion potential.
- Net operating income of $2,905,777* per annum.
*Approximately, as at 30 April 2024
Contacter l'équipe
